Pharmacotherapy of respiratory muscles in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 90, Issue 9, 1996, Pages 513-522

  Van Der Heijden, H F M ^a   Dekhuijzen, P N R ^a   Folgering, H ^a   Van Herwaarden, C L A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ANABOLIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROXATEROL; CLENBUTEROL; FENOTEROL; METHYLXANTHINE; NANDROLONE DECANOATE; REACTIVE OXYGEN METABOLITE; RECOMBINANT GROWTH HORMONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

BREATHING MUSCLE; CHEMOPROPHYLAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0029826728     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90143-2     Document Type: Review

References (101)

1. Decramer M, Gosselink H, Verschueren M, Demuynck K, Evers G. Medical consumption is related to muscle weakness in COPD patients. Am J Respir Crit Care Med 1994; 149: A140.
2. Ferguson GT. Respiratory muscle function in chronic obstructive pulmonary disease. Semin Respir Med 1993; 14: 430-445.
3. Fernandez E, Tanchocotan M, Make BJ. Methods to improve respiratory muscle function. Semin Respir Med 1993; 14: 446-465.
4. Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305: 249-252.
5. Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984; 311: 349-353.
6. Murciano D, Auclair M, Pariente R, Aubier M. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 1989; 320: 1521-1525.
7. Foxworth JW, Reisz GR, Knudson SM, Cuddy PG, Pyszczynski DR, Emory CE. Theophylline and diaphragmatic contractility. Investigations of a doseresponse relationship. Am Rev Respir Dis 1988; 138: 1532-1534.
8. Cooper CB, Davidson AC, Cameron IR. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease. Bull Eur Physiopathol Respir 1987; 23: 15-22.
9. Kongragunta VR, Druz WS, Sharp JT. Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 137: 662-667.
10. Decramer M, Deschepper K, Jiang TX, Derom E. Effects of aminophylline on respiratory muscle interaction. Am Rev Respir Dis 1991; 144: 797-802.
11. Wanke T, Merkle M, Zifko U et al. The effect of aminophylline on the force-length characteristics of the diaphragm. Am J Respir Crit Care Med 1994; 149: 1545-1549.
12. Gayan-Ramirez G, Decramer M. Inotropic effects of theophylline on foreshortened canine diaphragm. Am J Respir Crit Care Med 1994; 149: 920-924.
13. Gayan-Ramirez G, Buts N, Decramer M. Twitch potentiating effects of theophylline on rat diaphragm are enhanced by foreshortening. Eur Respir J 1994; 7: 292-297.
14. Gayan-Ramirez G, Palecek F, Chen Y, Janssens S, Decramer M. Inotropic effects of aminophylline on canine diaphragm are enhanced by hyperinflation. J Appl Physiol 1994; 76: 39-44.
15. Gauthier AP, Yan S, Sliwinski P, Macklem PT. Effects of fatigue, fiber length, and aminophylline on human diaphragm contractility. Am J Respir Crit Care Med 1995; 152: 204-210.
16. Bowman WC, Nott MW. Actions of sympathicomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev 1969; 21: 27-72.
17. Martin WH, Murphree SS, Saffitz JE. β-Adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red and intermediate skeletal muscle. Circ Res 1989; 64: 1096-1105.
18. Howell S, Fitzgerald RS, Roussos Ch. Effects of neostigmine and salbutamol on diaphragmatic fatigue. Respir Physiol 1985; 62: 15-29.
19. Howell S, Fitzgerald RS, Roussos Ch. Effects of aminophylline and salbutamol on diaphragmatic force during compensated metabolic acidosis. Am Rev Respir Dis 1986; 133: 407-413.
20. 2-agonists on the contractility of fatigued canine diaphragm in vivo. Respir Physiol 1993; 94: 25-34.
21. Aubier M, Viires N, Murciano D, Medrano G, Lecocguic Y, Pariente R. Effects and mechanism of action of terbutaline on diaphragmatic contractility and fatigue. J Appl Physiol 1984; 56: 922-929.
22. Suzuki S, Numata H, Sano F, Yoshiike Y, Miyashita A, Okubo T. Effects and mechanism of fenoterol on fatigued canine diaphragm. Am Rev Respir Dis 1988; 137: 1048-1054.
23. Derom E, Janssens S, Gurrieri G, Tjandramaga TB, Decramer M. Effects of broxaterol and theophylline on fatigued canine diaphragm in vivo: a randomized, controlled study. Am Rev Respir Dis 1992; 146: 22-25.
24. Van der Heijden HFM, Van Balkom RHH, Folgering HTM, Van Herwaarden CLA, Dekhuijzen PNR. Effects of salbutamol on rat diaphragm contractility. J Appl Physiol 1996; (in press).
25. Sieck GC, Fournier M. Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors. J Appl Physiol 1989; 66: 2539-2545.
26. Van der Heijden HFM, Folgering HTM, Van Herwaarden CLA, Dekhuijzen PNR. Inotropic effects of salbutamol on rat diaphragm contractility are potentiated by foreshortening. Am J Respir Crit Care Med 1996; 153: A686.
27. Javaheri S, Smith JT, Thomas JP, Guilfoile TD, Donovan EF. Albuterol has no effect on diaphragmatic fatigue in humans. Am Rev Respir Dis 1988; 137: 197-201.
28. Violante B, Pellegrino R, Vinay C, Selleri R, Ghinamo G. Failure of aminophylline and salbutamol to improve respiratory muscle function and exercise tolerance in healthy humans. Respiration 1989; 55: 227-236.
29. 2-agonists and caffeine on respiratory and limb muscle performance. Eur Respir J 1993; 6: 1192-1196.
30. 2-adrenoreceptor agonist, increases skeletal muscle strength in young men. Clin Sci 1992; 83: 615-621.
31. Suzuki J, Suzuki S, Okubo T. Effects of fenoterol on inspiratory effort sensation and fatigue during inspiratory threshold loading. J Appl Physiol 1996; 80: 727-733.
32. Stoller JK, Wiedemann HP, Loke P, Snyder P, Virgulto J, Matthay RA. Terbutaline and diaphragm function in chronic obstructive pulmonary disease: a double-blind randomized clinical trial. Br J Dis Chest 1988; 82: 242-250.
33. Jaeschke R, Guyatt GH, Willan A et al. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 1994; 49: 479-484.
34. Gigliotti F, Gurrieri G, Duranti R, Gorini M, Scano G. Effects of intravenous broxaterol on respiratory drive and neuromuscular coupling in COPD patients. Eur Respir J 1993; 6: 371-377.
35. 2-agonist (Broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction. Chest 1992; 101: 133-140.
36. Dekhuijzen PNR, Gayan-Ramirez G, de Bock V, Dom R, Decramer M. Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest 1993; 92: 1534-1542.
37. Lieberman DA, Faulkner JA, Craig AB, Maxwell LC. Performance and histochemical composition of guinea pig and human diaphragm. J Appl Physiol 1973; 34: 233-237.
38. 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am J Physiol 1994; 267: E475-E484.
39. Kusuhara N, Rothwell BC, Easton PA. Effect of β-adrenergics on respiratory muscle shortening and EMG activity in awake canines. Am J Respir Crit Care Med 1996; 153: A686.
40. McMillan DN, Noble BS, Maltin CA. The effect of the beta-adrenergic agonist clenbuterol on growth and protein metabolism in rat muscle cell cultures. J Anim Sci 1992; 70: 3014-3023.
41. Reeds PJ, Hay SM, Dorwood PM, Palmer RM. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Brit J Nutr 1986; 56: 249-258.
42. 2-adrenoceptor agonist clenbuterol. Br J Pharmacol 1987; 90: 601-607.
43. 2-adrenoceptor activation. Am J Physiol 1992; 263: E50-E56.
44. MacLennan PA, Edwards RHT. Effects of clenbuterol and propanolol on muscle mass. Biochem J 1989; 264: 573-579.
45. 2-agonist, retards atrophy in denervated muscles. Am J Physiol 1987; 252: E152-E155.
46. Agbenyega ET, Wareham AC. Effect of clenbuterol on normal and denervated muscle in growth and contractility. Muscle Nerve 1990; 13: 199-203.
47. Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Bioscience Reports 1987; 7: 143-149.
48. 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat. Metabolism 1990; 39: 647-650.
49. 2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats. Bioscience Reports 1987; 7: 933-940.
50. 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am J Physiol 1994; 267: C865-C868.
51. Dupont-Versteegden EE, Katz MS, McCarter RJ. Beneficial versus adverse effects of long term use of clenbuterol in mdx mice. Muscle Nerve 1995; 18: 1447-1459.
52. Hayes A, Williams DA. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol 1994; 21: 757-765.
53. 2-receptor agonist. Am J Physiol 1988; 254: E726-E732.
54. 2-agonist (clenbuterol) therapy produces diaphragm hypertrophy and dysfunction. Am Rev Respir Dis 1993; 147: A959.
55. Rollier H, Bisschop A, Gayan-Ramirez G, Derom E, Gosselink H, Decramer M. Clenbuterol enhances training effects in inspiratory muscles in rats. Eur Respir J 1995; 8 (Suppl. 19): 299s.
56. Maltin CA, Delday MI, Watson JS et al. Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci 1993; 84: 651-654.
57. Reid MB, Khawli FA, Moody MR. Reactive oxygen in skeletal muscle III. Contractility of unfatigued muscle. J Appl Physiol 1993; 75: 1081-1087.
58. Reid MB, Moody MR. Dimethyl sulfoxide depresses skeletal muscle contractility. J Appl Physiol 1994; 76: 2186-2190.
59. Khawli FA, Reid MB. N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro. J Appl Physiol 1994; 77: 317-324.
60. Anzueto A, Supinski GS, Levine SM, Jenkinson SG. Mechanisms of disease: Are oxygen-derived free radicals involved in diaphragmatic dysfunction? Am J Respir Crit Care Med 1994; 149: 1048-1052.
61. Supinski G, Nethery D, Dimarco A. Effect of free radical scavengers on endotoxin-induced respiratory muscle dysfunction. Am Rev Respir Dis 1993; 148: 1318-1324.
62. Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, West MS. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 1992; 73: 1797-1804.
63. Shindoh C, Dimarco A, Thomas A, Manubay P, Supinski G. Effects of N-acetylcysteine on diaphragm fatigue. J Appl Physiol 1990; 68: 2107-2113.
64. Diaz PT, Brownstein E, Clanton TL. Effects of N-acetylcysteine on in vitro diaphragm function are temperature dependent. J Appl Physiol 1994; 77: 2434-2439.
65. Supinski GS, Stofan D, Ciufo R, Dimarco A. N-acetylcysteine administration and loaded breathing. J Appl Physiol 1995; 79: 340-347.
66. Reid MB, Stokic DS, Koch SM, Khawli FA, Leis AA. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994; 94: 2468-2474.
67. Travaline JM, Sudarshan S, Roy B, Cordova F, Levenson V, Criner GJ. Effect of N-acetylcysteine on human diaphragm strength and fatiguability. Am J Respir Crit Care Med 1996; 153: A440.
68. Elashoff JD, Jacknow AD, Shain SG, Braunstein GD. Effects of anabolic-androgenic steroids on muscular strength. Ann Intern Med 1991; 115: 387-393.
69. Egginton S. Effects of an anabolic hormone on striated muscle growth and performance. Pflügers Arch 1987; 410: 349-355.
70. Egginton S. Effects of an anabolic hormone on aerobic capacity of rat striated muscle. Pflügers Arch 1987; 410: 356-361.
71. Bisschop APG, Dekhuijzen PNR, Gayan-Ramirez G, Buts N, Decramer M. Effects of nandrolone decanoate on rat respiratory muscles. Eur Respir J 1992; 5 (Suppl 15): 423.
72. Rollier H, Bisschop A, Gayan-Ramirez G, Derom E, Gosselink R, Decramer M. Treatment with nandrolone decanoate does not enhance training effects in rat diaphragm. Am J Respir Crit Care Med 1995; 151: A813.
73. deBoisblanc BP, Harris KY, Svec F, Summer WR. Dietary supplementation with dehydroepiandrosterone increases specific diaphragmatic tension generation in normal female rats. Am Rev Respir Dis 1993; 147: A957.
74. Yeh AY, Fournier M, Micevych PE, Sieck GC, Lewis MI. Impact of nandrolone treatment on hamster diaphragm structure and function. Am J Respir Crit Care Med 1996; 153: A686.
75. Prezant DJ, Valentine DE, Gentry EI, Richner B, Cahill J, Freeman K. Effects of short-term and long-term androgen treatment on the diaphragm in male and female rats. J Appl Physiol 1993; 75: 1140-1149.
76. DeLilly JA, LoRusso TJ, Fournier M, Micevych PE, Sieck GC, Lewis MI. Effects of anabolic steroids on diaphragm structure and function. Am J Respir Crit Care Med 1995; 151: A813.
77. Ferguson GT. Effects of cortisone and testosterone on diaphragmatic function and biochemistry in the rabbit. J Appl Physiol 1995; 78: 1459-1468.
78. Van Balkom RHH, Fransen JAM, Ginsel LA, Folgering HTM, Van Herwaarden CLA, Dekhuijzen PNR. Anabolic steroids antagonize functional and structural changes in rat diaphragm caused by prolonged administration of methylprednisolone. Am J Respir Crit Care Med 1996; 153: A685.
79. Schols AMW, Soeters PB, Mostert R, Pluymers RJ, Wouters EFM. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease; a placebo controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-1274.
80. Mayer M, Rosen F. Interaction of glucocorticoids and androgens with skeletal muscle. Metabolism 1977; 26: 937-945.
81. Wouters EFM, Schols AMWJ. Prevalence and pathophysiology of nutritional depletion in chronic obstructive pulmonary disease. Respir Med 1993; 87 (Suppl. B): 45-47.
82. Schols AMWJ, Soeters PB, Dingemans AMC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
83. Engelen MPKJ, Schols AMWJ, Baken WC, Wesseling GJ, Wouters EFM. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-1797.
84. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease; the National Institutes of Health intermittend positive-pressure breathing trial. Am Rev Respir Dis 1989; 139: 1435-1438.
85. Fernandez E, Park S, Make BJ. Nutritional issues in pulmonary rehabilitation. Semin Respir Med 1993; 14: 482-495.
86. Pingleton SK. Enterai nutrition in patients with respiratory disease. Eur Respir J 1996; 9: 364-370.
87. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991; 99: 1495-1500.
88. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J. Growth hormone and pulmonary disease; metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990; 150: 1225-1230.
89. Burdet L, de Muralt B, Schutz Y, Landry M, Pichard C, Fitting JW. Effects of growth hormone administration in underweight COPD patients. Am J Respir Crit Care Med 1996; 153: A453.
90. Pichard C, Kyle U, Chevrolet JG et al. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. Crit Care Med 1996; 24: 403-413.
91. Whittaker JS, Ryan CF, Buckley PA, Road JD. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis 1990; 142: 283-288.
92. Rogers RM, Donahoe M, Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis 1992; 146: 1511-1517.
93. Sridhar MK, Galloway A, Lean ME, Banham SW. An out-patient nutritional supplementation programme in COPD patients. Eur Respir J 1994; 7: 720-724.
94. Wilson DO, Rogers RM, Sanders MH, Pennock BE, Reilly JJ. Nutritional intervention in malnourished patients with emphysema. Am Rev Respir Dis 1986; 134: 672-677.
95. Lewis MI, LoRusso TJ, Fournier M. Effect of growth hormone and insulin like growth factor on diaphragm fiber size in malnourished adolescent rats. Am J Respir Crit Care Med 1995; 151: A814.
96. Feinberg AT, Fournier M, Lewis MI. The impact of growth factors on diaphragm fiber size with moderate nutritional deprivation. Am J Respir Crit Care Med 1996; 153: A686.
97. Lewis MI, LoRusso TJ, Fournier M. Effect of growth hormone and insulin-like growth factor-1 on the diaphragm of adolescent rats. Am J Respir Crit Care Med 1996; 153: A686.
98. Lanz JKJ, Donahoe M, Rogers RM, Ontell M. Effects of growth hormone on diaphragmatic recovery from malnutrition. J Appl Physiol 1992; 73: 801-805.
99. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990; 86: 265-272.
100. Bennet WM, Haymond MW. Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol 1992; 36: 161-164.
101. Petrof BJ, Gottfried SB, Eby J, LaManca J, Levine S. Growth hormone does not prevent corticosteroid-induced changes in rat diaphragm structure and function. J Appl Physiol 1995; 79: 1571-1577.